Loading organizations...
Loading organizations...
Innovative therapies for cancer patients using universal CAR T system.
Biosceptre has raised $15.4M across 2 funding rounds.
Biosceptre has raised $15.4M in total across 2 funding rounds.
Biosceptre has raised $15.4M in total across 2 funding rounds.
Biosceptre's investors include TUS-Holdings.
Biosceptre has raised $15.4M across 2 funding rounds. Most recently, it raised $10.7M Series A in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 15, 2017 | $10.7M Series A | TUS-Holdings | |
| Jul 9, 2014 | $4.7M Other Equity |